Blog

/Blog

Q4 Share Price Performance in 2017 – Part 1

By | January 17th, 2018|Analysis, Blog, Capital Markets|

          Q4 and 12-Month 2017 Share [...]

Canada in Science – December 1, 2017

By | December 1st, 2017|Blog, Canada in Science|

Welcome to your Canada in Science Review for December 1st, [...]

The Emergence of the HIV/AIDS Epidemic and How it Affected the Human Plasma Industry

By | November 9th, 2017|Beyond the Bench, Blog|

The Emergence of the HIV/AIDS Epidemic and How it Affected [...]

Q3 Share Price Performance in 2017 – Part 3

By | November 8th, 2017|Analysis, Blog, Capital Markets|

  Tier 2 Canadian Healthcare Companies: Moderately Negative with Usual [...]

Q3 Share Price Performance in 2017 – Part 2

By | November 8th, 2017|Analysis, Blog, Capital Markets|

  Tier 1 Canadian Healthcare Companies: Mixed and Volatile Performance [...]

Q3 Share Price Performance in 2017 – Part 1

By | November 8th, 2017|Analysis, Blog, Capital Markets|

Very High Volatility and Mixed Performance The key statistic from [...]

Canada in Science – November 3, 2017

By | November 3rd, 2017|Blog, Canada in Science|

  Welcome to your Canada in Science Review for November [...]

Acquisitions in the Life Sciences Start-Up Space: A Principal-Agent Problem in the Making

By | October 31st, 2017|Blog, Guest Editorial|

Acquisitions in the Life Sciences Start-Up Space: A Principal-Agent Problem [...]

Who gives a Superclusterf#$k?

By | October 26th, 2017|Blog, Health Innovation Nation|

Who gives a Superclusterf#$k? By Matthew Johnson You may have [...]

Progress Report: Canada’s Gilead of the North

By | October 25th, 2017|Blog, Guest Editorial|

Progress Report: Canada’s Gilead of the North By Roberto Bellini [...]